4527.T
ROHTO PHARMACEUTICAL CO.,LTD.
プライム · 医薬品 · 医薬品 · JP
JPY 3,057.00
+0.59%Price chart
Aug 5Aug 10Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
25.3x
EV/EBITDA
10.6x
Market Cap
JPY 690.77B
MomentumView details →
1D Return
+0.59%
YTD Return
+11.05%
RSI (14)
56.5
ValuationView details →
P/E (Fwd)
25.3x
EV/EBITDA
10.6x
Market Cap
JPY 690.77B
RSI (14)
56.5
MomentumView details →
1D Return
+0.59%
YTD Return
+11.05%
Similar companies
Latest newsMore news →
Rohto Pharmaceutical announced its first-quarter results, with operating profit of 13.7 billion yen, up 16.8% year-on-year, exceeding market expectations of about 12 billion yen.29d agoWellnex Life Limited entered into a binding agreement to sell its Pain Away business and assets to Mentholatum Australasia Pty Ltd for up to A$21.3 million, subject to shareholder approval.30d ago